Research Papers: Gerotarget (Focus on Aging):
Rapamycin promotes differentiation increasing βIII-tubulin, NeuN, and NeuroD while suppressing nestin expression in glioblastoma cells
PDF | HTML | Supplementary Files | How to cite
Metrics: PDF 2648 views | HTML 3573 views | ?
Michela Ferrucci1,*, Francesca Biagioni2,*, Paola Lenzi1, Stefano Gambardella2, Rosangela Ferese2, Maria Teresa Calierno2, Alessandra Falleni3, Alfonso Grimaldi4, Alessandro Frati2, Vincenzo Esposito2,4, Cristina Limatola2,4, Francesco Fornai1,2
1 Department of Translational Research and New Technologies in Medicine and Surgery, Human Anatomy, University of Pisa, Pisa, Italy
2 Istituto di Ricovero e Cura a Carattere Scientifico, Neuromed, Pozzilli, Isernia, Italy
3 Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy
4 Department of Physiology and Pharmacology, La Sapienza University of Rome, Roma, Italy
* These authors equally contributed to the manuscript
Francesco Fornai, email:
Keywords: mammalian target of rapamycin; stem cells; neuronal differentiation; transmission electron microscopy; qRT-PCR; Gerotarget
Received: September 27, 2016 Accepted: February 21, 2017 Published: March 18, 2017
Glioblastoma cells feature mammalian target of rapamycin (mTOR) up-regulation which relates to a variety of effects such as: lower survival, higher infiltration, high stemness and radio- and chemo-resistance. Recently, it was demonstrated that mTOR may produce a gene shift leading to altered protein expression. Therefore, in the present study we administered different doses of the mTOR inhibitor rapamycin to explore whether the transcription of specific genes are modified. By using a variety of methods we demonstrate that rapamycin stimulates gene transcription related to neuronal differentiation while inhibiting stemness related genes such as nestin. In these experimental conditions, cell phenotype shifts towards a pyramidal neuron-like shape owing long branches. Rapamycin suppressed cell migration when exposed to fetal bovine serum (FBS) while increasing the cell adhesion protein phospho-FAK (pFAK). The present study improves our awareness of basic mechanisms which relate mTOR activity to the biology of glioblastoma cells. These findings apply to a variety of effects which can be induced by mTOR regulation in the brain. In fact, the ability to promote neuronal differentiation might be viewed as a novel therapeutic pathway to approach neuronal regeneration.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.